CGRP and its receptors provide new insights into migraine pathophysiology (Q37785745)

23 August 2017

title

CGRP and its receptors provide new insights into migraine pathophysiology (English)

1 reference

23 August 2017

1 reference

1 reference

1 reference

23 August 2017

Lars Edvinsson

0 references

Peter J Goadsby

1 reference

23 August 2017

language of work or name

English

0 references

publication date

7 September 2010

1 reference

23 August 2017

published in

Nature Reviews Neurology

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

573-582

1 reference

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

31 March 2020

Serotonin and migraine

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

MECHANISM OF MIGRAINE HEADACHE AND ACTION OF ERGOTAMINE TARTRATE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The neurobiology of vascular head pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Timing and topography of cerebral blood flow, aura, and headache during migraine attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Perfusion weighted imaging during migraine: spontaneous visual aura and headache

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

PACAP38 induces migraine-like attacks in patients with migraine without aura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Migraine can be induced by sildenafil without changes in middle cerebral artery diameter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The vascular theory of migraine--a great story wrecked by the facts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

SUMATRIPTAN: a receptor-targeted treatment for migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Migraine--current understanding and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Lanepitant, an NK-1 antagonist, in migraine prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Delayed inflammation in rat meninges: implications for migraine pathophysiology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distrib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Steady-state visual evoked potentials and phase synchronization in migraine patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Synchrony: a neuronal mechanism for attentional selection?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide in the brain, spinal cord, and some peripheral systems.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Central projections of sensory innervation of the rat superficial temporal artery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Brain stem terminations of the trigeminal and upper spinal ganglia innervation of the cerebrovascular system: WGA-HRP transganglionic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide: multiple actions, multiple receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Neuronal messengers in the human cerebral circulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Fine structural analysis of calcitonin gene-related peptide in the mouse inferior olivary complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Physiological regulation of G4 AChe in fast-twitch muscle: effects of exercise and CGRP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide is localised to human airway nerves and potently constricts human airway smooth muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Distribution of vagal CGRP-immunoreactive fibers in the lower esophagus and the cardia of the stomach of the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and its role in regulating acetylcholinesterase expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Postjunctional inhibition of contractor responses in the mouse vas deferens by rat and human calcitonin gene-related peptides (CGRP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Regulation of motoneuronal calcitonin gene-related peptide (CGRP) during axonal growth and neuromuscular synaptic plasticity induced by botulinum toxin in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Long-term induction of beta-CGRP mRNA in rat lungs by allergic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Effect of calcitonin gene-related peptide (CGRP) on motility and on the release of substance P, neurokinin A, somatostatin and gastrin in the isolated perfused porcine antrum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Central projections of sensory innervation of the rat superior sagittal sinus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Central projections of the sensory innervation of the rat middle meningeal artery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Brainstem and thalamic projections from a craniovascular sensory nervous centre in the rostral cervical spinal dorsal horn of rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The colocalization of CGRP receptor and AMPA receptor in the spinal dorsal horn neuron of rat: a morphological and electrophysiological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Involvement of mu- and delta-opioid receptors in the antinociceptive effects induced by AMPA receptor antagonist in the spinal cord of rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

It is AMPA receptor, not kainate receptor, that contributes to the NBQX-induced antinociception in the spinal cord of rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Receptor localization in the mammalian dorsal horn and primary afferent neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Widespread expression of the AMPA receptor GluR2 subunit at glutamatergic synapses in the rat spinal cord and phosphorylation of GluR1 in response to noxious stimulation revealed with an antigen-unmasking method.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Differential effects of calcitonin gene-related peptide and calcitonin gene-related peptide 8-37 upon responses to N-methyl-D-aspartate or (R, S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate in spinal nociceptive neurons with knee joint inpu

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Glial cell line-derived neurotrophic factor increases calcitonin gene-related peptide immunoreactivity in sensory and motoneurons in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide receptor expression in the neurons and glia of developing rat cerebellum: an autoradiographic and immunohistochemical analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Brain stem activation in spontaneous human migraine attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide (CGRP) triggers Ca2+ responses in cultured astrocytes and in Bergmann glial cells from cerebellar slices.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Reduced cerebellar inhibition in migraine with aura: a TMS study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide: antinociceptive activity in rats, comparison with calcitonin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The spinal basis of opioid tolerance and physical dependence: Involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Pregnancy and sex steroid hormones enhance circulating calcitonin gene-related peptide concentrations in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Randomized, controlled trial of telcagepant for the acute treatment of migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Suppression of spreading depression-like events in locusts by inhibition of the NO/cGMP/PKG pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The Mode of Action of Sumatriptan is Vascular? A Debate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

The pharmacology of headache

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Therapeutic potential of novel glutamate receptor antagonists in migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Increased familial risk and evidence of genetic factor in migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Analysis of 31 families with an apparently autosomal-dominant transmission of migraine with aura in the nuclear family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide is a potent vasodilator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide: functional role in cerebrovascular regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Neurobiology in primary headaches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Calcitonin gene-related peptide in thyroid nerve fibers and C cells: effects on thyroid hormone secretion and response to hypercalcemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Messenger molecules and receptor mRNA in the human trigeminal ganglion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.127

Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications

31 March 2020

1 reference

12 December 2020

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

1 reference

12 December 2020

Neuron-glia interactions at the neuromuscular synapse.

1 reference

12 December 2020

Immunolocalization of CGRP, NPY and PGP 9.5 in guinea pig skin

1 reference

12 December 2020

Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally

1 reference

12 December 2020

The electrophysiology of migraine

1 reference

12 December 2020

Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP.

1 reference

12 December 2020

Temporal and spatial distribution of VIP, CGRP and their receptors in the development of airway hyperresponsiveness in the lungs.

1 reference

12 December 2020

Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug

1 reference

12 December 2020

No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials

1 reference

12 December 2020

The inheritance of migraine with aura estimated by means of structural equation modelling

1 reference

12 December 2020

Subclinical cerebellar impairment in the common types of migraine: a three-dimensional analysis of reaching movements

1 reference

12 December 2020

10.1038/NRNEUROL.2010.127

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

1003256942

0 references

1 reference